Bio-Rad and German-based biotech Qiagen weighing latest tie-up in medical-diagnostic market
Bio-Rad Laboratories Inc. is in talks to combine with fellow life-sciences company Qiagen NV in…
Read MoreBio-Rad Laboratories Inc. is in talks to combine with fellow life-sciences company Qiagen NV in…
Read MoreHello! In this week’s ETF Wrap, health-care ETFs take the spotlight as investors get defensive…
Read More
Opinion: Investors in drug stocks should ignore dubious valuations based on rigged methodologies
The investment firm Morningstar has announced that it will now pick drug stocks based upon…
Read More